TNF and rheumatoid arthritis: Patients with RA are more likely to be persistent and adherent to combination therapy with a tumor necrosis factor alpha inhibitor and methotrexate than combination therapy with methotrexate, sulfasalazine, and hydroxychloroquine.(47, 48)